SCHEDULE: Oxford Finance Discloses 16.5% Stake in KALA BIO
Beneficial Ownership Report
Oxford Finance LLC has reported a 16.5% beneficial ownership stake in KALA BIO, Inc., holding 1,620,000 shares of common stock.
Summary
- Oxford Finance LLC, a Delaware entity, has filed a Schedule 13G indicating beneficial ownership of KALA BIO, Inc. common stock.
- The reporting person, Oxford Finance LLC, holds 1,620,000 shares of KALA BIO, Inc. common stock.
- This ownership represents 16.5% of KALA BIO, Inc.'s outstanding common stock.
- The calculation of ownership is based on 9,829,725 shares of Common Stock, comprising 8,209,725 shares outstanding as of November 18, 2025, and an additional 1,620,000 shares issued to Oxford Finance LLC thereafter.
- Oxford Finance LLC has sole voting power and sole dispositive power over all 1,620,000 shares.
- The filing certifies that the securities were not acquired or held for the purpose of changing or influencing the control of KALA BIO, Inc.
Sentiment
Score: 5
Explanation: The filing is a standard disclosure of beneficial ownership and does not inherently convey positive or negative sentiment. It is a factual report of an institutional stake.
Future Outlook
This filing does not contain any forward-looking statements or guidance from KALA BIO, Inc. or Oxford Finance LLC regarding future performance or operations.
Industry Context
This Schedule 13G filing indicates a significant institutional stake in KALA BIO, Inc. by Oxford Finance LLC. Such filings are common for financial institutions that acquire a substantial, but passive, ownership position in a company, often as part of a lending arrangement or investment. It signals a notable investor's confidence or involvement with the company, without necessarily implying an intent to influence management or control.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional holder may provide a degree of confidence or stability, indicating a substantial investor has a stake in the company. It also clarifies the ownership structure.
- Company Management: Awareness of a large, passive institutional holder like Oxford Finance LLC is important for understanding the shareholder base, though this filing explicitly states no intent to influence control.
Key Dates
| Date | Description |
|---|---|
| 11/18/2025 | Date as of which 8,209,725 shares of Common Stock were reported outstanding in the Issuer's Form 10-Q. |
| 11/25/2025 | Date of event which requires the filing of this statement. |
| 12/03/2025 | Date the Schedule 13G was signed by Oxford Finance LLC. |
Keywords
KALA BIO Inc., Oxford Finance LLC, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Ownership, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.